| 1999 |
T-STAR/ETOILE (KHDRBS3) was identified as a novel RNA-binding protein closely related to SAM68, discovered via yeast two-hybrid screen using testis cDNA as bait for RBM (Y-chromosome RNA-binding protein). T-STAR interacts with RBM and other hnRNP G family members. When fused to GFP and transfected into HeLa cells, T-STAR accumulated in a novel nuclear compartment adjacent to the nucleolus but distinct from the peri-nucleolar compartment. |
Yeast two-hybrid screen, GFP fusion transfection, subcellular localization imaging |
Human molecular genetics |
Medium |
10332027
|
| 1999 |
SLM-2 (KHDRBS3) is an RNA-binding protein that is NOT tyrosine phosphorylated by Src or p59(fyn), and does not associate with the SH3 domains of p59(fyn), Grb-2, PLCgamma-1, or p120(rasGAP), unlike its paralog SLM-1. This distinguishes SLM-2 from SLM-1 and SAM68 as a non-adapter protein for these signaling partners. |
In vitro kinase assay, SH2/SH3 domain binding assays |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
10077576
|
| 2001 |
Overexpression of T-STAR (KHDRBS3) in SV40-transformed immortalized cells resulted in strong reduction of colony formation; deletion of the RNA-binding domain abrogated this growth-inhibitory effect, indicating the RNA-binding domain is required for T-STAR's growth-inhibitory function. |
Overexpression with deletion mutants, colony formation assay |
Cell growth & differentiation |
Medium |
11714634
|
| 2004 |
The tyrosine kinase BRK/Sik phosphorylates SLM-2 (KHDRBS3), and this phosphorylation inhibits the RNA-binding ability of SLM-2. Expression of active BRK/Sik resulted in increased SLM-2 phosphorylation and increased nuclear retention of BRK/Sik. |
In vitro kinase assay, RNA-binding assay, phosphorylation analysis |
The Journal of biological chemistry |
High |
15471878
|
| 2004 |
SIAH1 (E3 ubiquitin ligase) binds to an octapeptide sequence in human T-STAR (KHDRBS3) and targets it for proteasome-dependent degradation. Rodent T-STAR orthologues lack this SIAH1-binding site and are not degraded; a double amino acid substitution in mouse T-STAR that mimics the human SIAH1-binding site brings mouse T-STAR under SIAH1 control. Human T-STAR-dependent alternative splicing is modulated by SIAH1, demonstrating that proteasomal degradation controls T-STAR splicing activity. |
Yeast two-hybrid screen, co-immunoprecipitation, proteasome inhibitor assays, minigene splicing assays, site-directed mutagenesis |
Human molecular genetics |
High |
15163637
|
| 2009 |
SLM-2 (KHDRBS3) binds RNA via a bipartite U(U/A)AA direct repeat motif identified by SELEX. Both halves of the bipartite motif are required for high-affinity RNA binding by SLM-2. |
SELEX (Systematic Evolution of Ligands by EXponential enrichment), in vitro RNA binding assays |
BMC molecular biology |
High |
19457263
|
| 2009 |
Mouse T-STAR (KHDRBS3) directly binds Fabp9 mRNA, with binding sites located in a short sequence of the coding region and 3' UTR of Fabp9 mRNA, as identified from testis extract by SNAAP (isolation of specific nucleic acids associated with proteins). |
SNAAP method (protein-RNA co-isolation from testis extract), direct RNA binding assay |
Biochemistry. Biokhimiia |
Low |
19916944
|
| 2011 |
SerpinB5 physically interacts with KHDRBS3 in gastric cancer cells, confirmed by co-immunoprecipitation. KHDRBS3 interacts with FBXO32 mRNA, as shown by RNA co-immunoprecipitation. KHDRBS3 protein is primarily detected in the nucleus of normal mucosal cells. |
Yeast two-hybrid screening, co-immunoprecipitation, RNA co-immunoprecipitation, Western blotting, immunohistochemistry |
Oncology reports |
Medium |
21725612
|
| 2013 |
T-STAR (KHDRBS3) acts as a potent splicing repressor of the alternatively spliced segment 4 (AS4) exons from each of the Neurexin1-3 genes, and exon 23 of Stxbp5l, in the mouse brain. T-STAR expression is highest in forebrain structures (hippocampus), which correlates with maximal Neurexin1-3 AS4 splicing repression. In T-STAR null mice, AS4 splicing repression dramatically decreased despite co-expression of Sam68. T-STAR controls Neurexin2 AS4 splicing through a UWAA-rich response element immediately downstream of the regulated exon. Human T-STAR represses zebrafish Nrxn3 AS4 splicing, indicating an ancient mechanism. |
T-STAR null mouse generation, transcriptome-wide splicing analysis, minigene transfection assays, cross-species functional assays |
PLoS genetics |
High |
23637638
|
| 2016 |
Crystal/NMR structure of T-STAR (KHDRBS3) STAR domain revealed an unexpected dimerization mode different from other STAR family members. This unique dimerization interface is required for biological activity in splicing regulation, and increased RNA affinity through dimer formation enables functional target selection within the transcriptome. |
Crystal structure determination, NMR, mutagenesis of dimerization interface, splicing assays |
Nature communications |
High |
26758068
|
| 2016 |
SLM2 (KHDRBS3) controls the splicing of Tomosyn2, LysoPLD/ATX, Dgkb, Kif21a, and Cask in addition to Neurexin1-3 AS4. SLM2 levels are maintained by a homeostatic feedback control pathway (autoregulation) that predates the divergence of SLM2 and Sam68. Loss of SLM2 in null mice decreases cortical neural network activity dependent on synaptic connections between SLM2-expressing pyramidal neurons and interneurons; these mice are also anxious and show decreased novel object recognition. |
Slm2-null mice, RNA-seq splicing analysis, cortical network electrophysiology, behavioral assays |
Cell reports |
High |
28009295
|
| 2017 |
SLM2 (KHDRBS3) and Sam68 show paralog-specific activity on Neurexin2 AS4 splicing despite similar RNA binding. A protein domain-swap experiment identified a region including the STAR domain (not the RNA-contact residues) that differentiates SLM2 and Sam68 activity. The density of shared RNA binding sites flanking a target exon — rather than different paralog-specific protein-RNA contacts — controls functional target specificity: doubling the number of binding sites around Neurexin2 AS4 switched it to joint control by both paralogs. |
Domain-swap mutagenesis, in vitro RNA binding, in vivo splicing assays, minigene reporter assays |
Nucleic acids research |
High |
27994030
|
| 2017 |
Knockdown of KHDRBS3 in human ovarian cancer CAOV-3 cells caused G0/G1 phase cell cycle arrest and inhibited cell proliferation, indicating KHDRBS3 is required for cell cycle progression in these cells. |
siRNA knockdown, MTT proliferation assay, flow cytometry cell cycle analysis |
Xi bao yu fen zi mian yi xue za zhi |
Low |
28871947
|
| 2017 |
SLM2 (KHDRBS3) expression in cerebellar neurons controls AS4 splicing of Nrxn genes; ectopic SLM2 expression caused marked skipping of exon 20 of Nrxn AS4. SLM2-dependent AS4 splicing of Nrxn3 is required for neuroligin-induced GABAergic presynaptic differentiation: lentiviral Nrxn3 containing exon 20 rescued reduced GABAergic contacts in SLM2-overexpressing co-cultures. |
Lentiviral overexpression, neuron-fibroblast co-culture synapse formation assay, splicing analysis |
Biochemical and biophysical research communications |
Medium |
28939043
|
| 2018 |
SALL4 transcription factor upregulates KHDRBS3 expression, and KHDRBS3 in turn modulates CD44 alternative splicing to produce a CD44 variant (CD44v) lacking exons 8 and 9. This CD44v isoform positively contributes to cancer stemness and anoikis resistance in basal-like breast cancer cells. CD44v overexpression rescued the reduction in sphere formation caused by KHDRBS3 knockdown. |
shRNA knockdown, overexpression, sphere formation assay, RT-PCR splicing analysis, anoikis assay |
Cancer medicine |
Medium |
29356399
|
| 2019 |
Metadherin interacts with T-STAR (KHDRBS3) as shown by yeast two-hybrid assay and immunoprecipitation. Metadherin influences splice site selection in CD44v5-luc minigene reporter assays in a dose-dependent manner. |
Yeast two-hybrid, immunoprecipitation, minigene splicing reporter assay |
Cancers |
Medium |
31450747
|
| 2019 |
KHDRBS3 binds to circular RNA DENND4C (cDENND4C) and increases its stability in glioma endothelial cells. This KHDRBS3-cDENND4C interaction regulates blood-tumor barrier (BTB) permeability via a cDENND4C/miR-577 axis that controls tight junction proteins ZO-1, occludin, and claudin-1. |
RNA immunoprecipitation, knockdown, overexpression, permeability assays, Western blotting for tight junction proteins |
Cell death & disease |
Low |
31296839
|
| 2020 |
KHDRBS3 regulates CD44 variant expression in gastric cancer cells, contributing to acquisition of cancer stem cell-like features including multi-drug resistance and organoid formation in 5-FU-resistant gastric cancer organoids. |
Organoid culture, microarray analysis, RT-PCR, Western blotting, drug resistance assays |
Oncogene |
Low |
33046798
|
| 2021 |
SLM2/KHDRBS3 binds mRNAs of sarcomere constituents MYL2, TNNI3, TNNT2, TPM1/2, and TTN in the human heart (identified by RNA-immunoprecipitation sequencing). SLM2 mediates intron retention, prevents exon exclusion, and thereby controls alternative splicing of the PEVK domain-encoding region and another part of the I-band region of titin mRNA. |
RNA-immunoprecipitation sequencing (RIP-seq), RNA-seq splicing analysis, cardiac tissue from DCM patients |
Genomics, proteomics & bioinformatics |
Medium |
34273561
|
| 2021 |
SLM2 (KHDRBS3) expression in cortical VIP-positive GABAergic interneurons (originating from caudal ganglionic eminence) contributes to GABAergic synapse specification. SLM2 knockdown reduced NRX AS4(-) isoform expression and weakened LRRTM2-induced synapse formation; addition of NRX AS4(-) rescued synaptic formation in SLM2 knockdown neurons. |
In vitro knockdown, artificial synapse formation assay, splicing analysis, immunostaining for interneuron subtypes |
Neurochemical research |
Medium |
34196888
|
| 2022 |
KHDRBS3 interacts with lncRNA MIR17HG (RNA immunoprecipitation). KHDRBS3 knockdown reduced paclitaxel resistance and glycolysis in ovarian cancer cells; overexpression of KHDRBS3 enhanced these phenotypes, which were rescued by MIR17HG overexpression. MIR17HG targets CLDN6 3'UTR to negatively regulate CLDN6 expression, defining a KHDRBS3-MIR17HG-CLDN6 regulatory axis. |
RNA immunoprecipitation, MTT assay, colony formation, apoptosis assay, Seahorse glycolysis assay, xenograft model |
Life sciences |
Low |
35051418
|
| 2023 |
KHDRBS3 directly binds YWHAZ mRNA (encoding 14-3-3ζ), as demonstrated by RNA pull-down and RNA immunoprecipitation assays. KHDRBS3 upregulates 14-3-3ζ protein expression, and 14-3-3ζ silencing reversed the promotion of proliferation and glycolysis caused by KHDRBS3 overexpression in hepatocellular carcinoma cells. |
RNA pull-down, RNA immunoprecipitation, lentiviral knockdown/overexpression, xenograft model, functional proliferation and glycolysis assays |
Cancer cell international |
Medium |
37848941
|
| 2023 |
circHECTD1 interacts with KHDRBS3 (demonstrated by RNA pull-down and RIP), and this interaction enhanced stability of EZH2 mRNA, increasing EZH2 protein levels and promoting proliferation and migration of vascular smooth muscle cells. |
RNA pull-down, RNA immunoprecipitation, knockdown/overexpression, CCK8, transwell assays |
Journal of inflammation research |
Low |
36998321
|
| 2025 |
In hepatocellular carcinoma, the circFOXP1-encoded protein p196 directly binds KHDRBS3 through its D2 domain, forming a complex that stabilizes ULK1 mRNA, thereby increasing ULK1 protein levels, activating autophagy and accelerating tumor progression. |
RNA immunoprecipitation, co-immunoprecipitation, RNA pull-down, in vitro binding assays, loss- and gain-of-function assays |
International journal of nanomedicine |
Low |
40292405
|
| 2026 |
In a mouse model of endothelin-1 overexpression, Khdrbs3 was the top upregulated gene in mesenteric arteries. KHDRBS3 protein was increased in aortic endothelial cells and vascular smooth muscle cells. KHDRBS3 acted as a splicing regulator of VEGFA pre-mRNA, with ET-1 overexpression upregulating Vegfa164 (exon 7 retention) and Vegfa188 (exons 6 and 7 retention) isoforms and downregulating Vegfa120. RNA-immunoprecipitation sequencing from DCM myocardium identified VEGFA and four VSMC-specific pre-mRNAs as KHDRBS3 targets. |
RNA-sequencing, RT-qPCR, immunofluorescence microscopy, RNA-immunoprecipitation sequencing (RIP-seq), tamoxifen-inducible transgenic mouse model |
Journal of hypertension |
Medium |
42253124
|